Ashley Pereira

Ashley Pereira, Pharm.D. has served as Senior Vice President of Regulatory Affairs since September 2021. His responsibilities include overseeing the regulatory strategies and activities that advance the development of clinical programs and maintaining effective and collaborative working relationships with regulatory authorities worldwide. He brings nearly 20 years of clinical-regulatory drug development experience. Dr. Pereira was most recently the Global Regulatory Sciences Deputy Head for hematology therapeutic at Bristol-Myers Squibb (BMS) where he provided direct oversight to the multiple myeloma and lymphoma regulatory teams. Previously, he held numerous roles with increasing responsibilities at BMS, including supporting the development of OPDIVO® (Nivolumab) as the Global Regulatory Group Leader for the Head & Neck, Gastric, Hepatocellular Carcinoma development teams. Dr. Pereira was also the regulatory head for new oncology assets including major collaborations/partnered assets in late stage development. Dr. Pereira holds a Doctorate of Pharmacy from Philadelphia College of Pharmacy & Science.